AU2003248355A1 - Salt of a pyridyl ethanolamine derivative and its use as a beta-3-adrenergic receptor agonist - Google Patents
Salt of a pyridyl ethanolamine derivative and its use as a beta-3-adrenergic receptor agonistInfo
- Publication number
- AU2003248355A1 AU2003248355A1 AU2003248355A AU2003248355A AU2003248355A1 AU 2003248355 A1 AU2003248355 A1 AU 2003248355A1 AU 2003248355 A AU2003248355 A AU 2003248355A AU 2003248355 A AU2003248355 A AU 2003248355A AU 2003248355 A1 AU2003248355 A1 AU 2003248355A1
- Authority
- AU
- Australia
- Prior art keywords
- pyridyl
- beta
- salt
- receptor agonist
- adrenergic receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36024802P | 2002-02-27 | 2002-02-27 | |
| US60/360,248 | 2002-02-27 | ||
| PCT/IB2003/000575 WO2003072571A1 (en) | 2002-02-27 | 2003-02-17 | Salt of a pyridyl ethanolamine derivative and its use as a beta-3-adrenergic receptor agonist |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003248355A1 true AU2003248355A1 (en) | 2003-09-09 |
Family
ID=27766205
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003248355A Abandoned AU2003248355A1 (en) | 2002-02-27 | 2003-02-17 | Salt of a pyridyl ethanolamine derivative and its use as a beta-3-adrenergic receptor agonist |
Country Status (8)
| Country | Link |
|---|---|
| AR (1) | AR038603A1 (en) |
| AU (1) | AU2003248355A1 (en) |
| GT (1) | GT200300044A (en) |
| PA (1) | PA8567601A1 (en) |
| PE (1) | PE20030900A1 (en) |
| TW (1) | TW200305414A (en) |
| UY (1) | UY27678A1 (en) |
| WO (1) | WO2003072571A1 (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9812709D0 (en) * | 1998-06-13 | 1998-08-12 | Glaxo Group Ltd | Chemical compounds |
| CZ20031012A3 (en) * | 2000-10-20 | 2004-04-14 | Pfizer Products Inc. | Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists |
-
2003
- 2003-02-17 AU AU2003248355A patent/AU2003248355A1/en not_active Abandoned
- 2003-02-17 WO PCT/IB2003/000575 patent/WO2003072571A1/en not_active Ceased
- 2003-02-24 PE PE2003000179A patent/PE20030900A1/en not_active Application Discontinuation
- 2003-02-25 UY UY27678A patent/UY27678A1/en not_active Application Discontinuation
- 2003-02-25 AR ARP030100606A patent/AR038603A1/en not_active Application Discontinuation
- 2003-02-26 TW TW092104035A patent/TW200305414A/en unknown
- 2003-02-26 GT GT200300044A patent/GT200300044A/en unknown
- 2003-02-26 PA PA20038567601A patent/PA8567601A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| UY27678A1 (en) | 2003-10-31 |
| PE20030900A1 (en) | 2003-10-25 |
| TW200305414A (en) | 2003-11-01 |
| WO2003072571A1 (en) | 2003-09-04 |
| PA8567601A1 (en) | 2003-12-10 |
| AR038603A1 (en) | 2005-01-19 |
| GT200300044A (en) | 2003-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003302919A1 (en) | Pyridine derivatives as jnk inhibitors and their use | |
| AU2003290700A1 (en) | Farnesoid x receptor agonists | |
| AU2002210782A1 (en) | Amide derivatives as nmda receptor antagonists | |
| AU2003260345A1 (en) | 2-phenylpyridin-4-yl derivatives as alk5 inhibitors | |
| AU2003228485A1 (en) | Farnesoid x-activated receptor agonists | |
| HUS1400047I1 (en) | Quinoline derivatives and their use as mycobacterial inhibitors | |
| AU2003235676A1 (en) | Tricyclic-bis-enone derivatives and methods of use thereof | |
| AU2003280188A1 (en) | Benzoxazin-3-ones and derivatives thereof as inhibitors of pi3k | |
| AU2003226927A1 (en) | Novel carboxamide compounds for use in mch receptor related disorders | |
| AU2003288640A1 (en) | Benzamide inhibitors of the p2x7 receptor | |
| AU2003241833A1 (en) | Beta-ALANINE DERIVATIVE AND USE THEREOF | |
| AU2003251705A1 (en) | Idol derivatives as new thyroid receptor agonist ligands and methods | |
| AU2003202116A1 (en) | Nicotinamide derivatives useful as pde4 inhibitors | |
| AU2003275838A1 (en) | Pyrrolidin-2-on derivatives as ep4 receptor agonists | |
| AU2003232848A1 (en) | Phenylaminopyrimidines and their use as rho-kinase inhibitors | |
| AU2003281044A1 (en) | Pyrrolopyridine derivative and use thereof | |
| AU2003207023A1 (en) | Piperidine derivatives and their use as antagonists of tachykinins | |
| IL176515A0 (en) | 1,3-diphenylprop-2-en-1-one derivative compounds, preparation method thereof and uses of same | |
| AU2003218660A8 (en) | Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor liga ds | |
| AU2003252314A1 (en) | 4-substituted quinazoline-8-carboxyamide derivative and pharmaceutically acceptable addition salt thereof | |
| AUPQ570100A0 (en) | Beta-alanine derivatives and their use as receptor antagonists | |
| AU2003268464A1 (en) | INDOLE-TYPE DERIVATIVES AS INHIBITORS OF p38 KINASE | |
| AU2003281691A1 (en) | Furoisoquinoline derivative and use thereof | |
| AU2003248355A1 (en) | Salt of a pyridyl ethanolamine derivative and its use as a beta-3-adrenergic receptor agonist | |
| AU2003229459A1 (en) | Methods of using thiazolidinedithione derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |